| abstract |
An object of the present invention is to increase the effectiveness of an α2 adrenergic agonist component. A composition useful for enhancing the effectiveness of an α2 adrenergic agonist component comprises a carrier component, an α2 adrenergic agonist component, and a solubility enhancing component that promotes solubilization of the α2 adrenergic agonist component. In one aspect, the α2 adrenergic agonist component includes an α2 adrenergic agonist. In another embodiment, the solubility enhancing component includes povidone or polyvinyl alcohol. [Selection] Figure 1 |